Industry Panel Webinar: How GenAI is Changing Regulatory Affairs

Hans van Leeuwen
Global Head of Regulatory Operations – Astellas

Steve Gens
Managing Partner – Gens & Associates

Michael Sonntag
Director, Global Regulatory Affairs & PV – Wörwag Pharma

See where AI and automation drive the greatest time and cost savings.

Second Life Sciences GenAI Council Expands Global Perspective

Following a successful inaugural gathering in the USA in February, leading global pharmaceutical organizations & AI specialists will meet in Switzerland on May 15th to further fuel adoption of next-generation technologies transforming Life Sciences R&D.

Pioneering the Next Frontier: ArisGlobal Unveils Cutting-Edge Safety & Regulatory Product Offerings Powered by Generative AI

Launched at Breakthrough 2024, ArisGlobal announced Advanced Intake, Real-World Data Subscription, & its Next-Generation LifeSphere Regulatory Platform LONDON, UK – March 20, 2024 – ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, today announced three cutting-edge product offerings that will transform pharmacovigilance and regulatory operations.

ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.

Quick Links

Follow Us

© 2024 ArisGlobal – All Rights Reserved

Accessibility by WAH